Clinical Trials Browser

Phase 2 × Embolization, Therapeutic × Dermatologic × Clear all

NCT03472586 2025-04-24

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

Phase 2 Completed

14 enrolled 8 charts

Uveal Melanoma